Skip to content
How it works
The SyMRI® technology is based on rapid MR quantification of the patient’s physical properties. Using the SyMRI approach, a single, short MRI quantification scan measures physical properties of the patient. Using this data, conventional contrast images can be synthesized at any combination of TR, TE and inversion delay time TI. This provides a short scan time and a robust and flexible examination since a whole range of images can be synthesized even after the patient has left. Furthermore tissues can be recognized automatically with synthetic tissue mapping, providing objective, quantitative, decision support.
Using SyMRI, clinicians can capture multiple image contrasts in a single scan, providing an efficient workflow and the possibility of examining more patients per day. With synthetic MRI, the contrast can be adjusted after the scan, creating additional images without re-calling the patient. Automatic segmentation of brain tissue provides objective decision support based on quantitative data.
SyMRI is a CE-marked product, available in the product packages SyMRI IMAGE, SyMRI NEURO and SyMRI NEURO REMyDI. SyMRI is FDA 510(k) pending. SyMRI is also available in a Research Edition package.
SyMRI is a registered trademark in Europe and USA.